The Dow surged 532.31 points, or 2.21%, to close at 24,663.86. The S&P 500 climbed 2.66% to 2,939.51. The Nasdaq Composite advanced 3.57% to 8,914.71. Wednesday's rally on Wall Street was sparked by positive data from a potential coronavirus treatment from Gilead Sciences .
A study of Gilead's remdesivir drug conducted by the National Institute of Allergy and Infectious Disease s met its primary endpoint, the drugmaker said . Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said remdesivir shows a "clear-cut" positive effect when treating the virus. The Gilead news along with the strong move higher from Alphabet offset news of a steep drop in U.S. economic activity. U.S. GDP shrank by 4.8% in the first quarter for the country's biggest contraction since the financial crisis.
Gilead shares jumped 5.68% on the back of its announcements while Alphabet gained 8.89% after reporting a slower-than-expected decline in revenue growth.
Weekly jobless claims data are scheduled for release. McDonald's , Twitter and Amazon are among the companies scheduled to report earnings on Thursday.
Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.
